Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Attralus, Inc.

Clinical trials sponsored by Attralus, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for amyloidosis patients: Long-Term safety study of AT-02 underway Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 1

New hope for amyloidosis patients: Long-Term safety study of AT-02 underway

Disease control Ongoing

This study is for people with systemic amyloidosis, a disease where abnormal proteins build up in organs. It tests the long-term safety of an experimental drug called AT-02. About 120 adults will receive the drug and be monitored for side effects and how the drug behaves in the b…

Phase 2 • Sponsor: Attralus, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC